Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations

Mutations in the “guardian of the genome” TP53 predominate in solid tumors. In addition to loss of tumor suppressor activity, a specific subset of missense mutations confers additional oncogenic properties. These “gain-of-function” (GOF) mutations portend poor prognosis across cancer types regardles...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiangbing, Yang, Shujie, Li, Yujun, Li, Yiyang, Devor, Eric J., Bi, Jianling, Wang, Xinhao, Umesalma, Shaikamjad, Quelle, Dawn E., Thiel, William H., Thiel, Kristina W., Leslie, Kimberly K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311857/
https://www.ncbi.nlm.nih.gov/pubmed/30647797
http://dx.doi.org/10.1155/2018/3810108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311857/
https://www.ncbi.nlm.nih.gov/pubmed/30647797
http://dx.doi.org/10.1155/2018/3810108

Ejemplares similares